Objective: Among children with epilepsy, to develop and evaluate a model to predict emergency department (ED) use, an indicator of poor disease control and/ or poor access to care. Methods: We used electronic health record data from 2013 to predict ED use in 2014 at 2 centers, benchmarking predictive performance against machine learning algorithms. We evaluated algorithms by calculating the expected yearly ED visits among the 5% highest risk individuals. We estimated the breakeven cost per patient per year for an intervention that reduced ED visits by 10%. We estimated uncertainty via cross-validation and bootstrapping. Results: Bivariate analyses showed multiple potential predictors of ED use (demographics, social determinants of health, comorbidities, insurance, disease severity, and prior health care utilization). A 3-variable model (prior ED use, insurance, number of antiepileptic drugs [AEDs]) performed as well as the best machine learning algorithm at one center (N = 2730; ED visits among top 5% highest risk, 3-variable model, mean = 2.9, interquartile range [IQR] = 2.7-3.1 vs Random Forest, mean = 2.9, IQR = 2.7-3.1), and superior at the second (N = 784; mean = 2.5, IQR = 2.2-2.9 vs mean = 1.9, IQR = 1.6-2.5). The perpatient-per-year breakeven point using this model to identify high-risk individuals was $958 (95% confidence interval [CI] = $568-$1390) at one center and $1086 (95% CI = $886-$1320) at the second. Significance: Prior ED use, insurance status, and number of AEDs, taken together, predict future ED use for children with epilepsy. Our estimates suggest a program targeting high-risk children with epilepsy that reduced ED visits by 10% could spend approximately $1000 per patient per year and break even. Further work is indicated to develop and evaluate such programs.
| INTRODUCTION
Epilepsy is ambulatory care sensitive-ie, high-quality care can help people with epilepsy avoid unnecessary emergency department (ED) visits and hospital admissions. [1] [2] [3] [4] Several initiatives have demonstrated such reductions may be possible for both adults and children with epilepsy. [5] [6] [7] [8] People with epilepsy at high risk for frequent ED visits are an ideal target group for enrollment in programs to enhance outpatient care, because frequent ED use indicates poor access to care and/or poor disease control. [9] [10] [11] [12] Quantifying "high risk" in this context is an active area of research. 13 Prior work using data from multiple hospitals found that future frequent ED use could be accurately predicted solely by examining prior ED use, despite the availability of additional demographics and comorbidity data. 14 However, there were important limitations. The data were from a single metropolitan area, did not include markers of disease severity, and did not include insurance status, an important determinant of health outcomes in the United States. In addition, the findings were of uncertain utility, because the data source (a health information exchange organization) is not routinely available to caregivers. Finally, the prior work did not include estimates of the potential impact of using such a predictive model to enroll children into an intervention. This article aims to address those limitations. First, we use electronic health record (EHR) data, which is readily available to health centers, and includes indicators of insurance status and disease severity. Second, we analyzed data from 2 tertiary pediatrics centers, to improve generalizability. Third, we performed both practical and financial analyses to evaluate the potential impact of an intervention targeted to high-risk individuals. We benchmarked predictive accuracy to the performance of machine learning algorithms.
| MATERIALS AND METHODS

| Study design
This was a retrospective cohort study to predict frequent ED use among children with epilepsy at 2 centers. Institutional review boards at Weill Cornell Medical Center (WCM) and Nationwide Children's Hospital (NCH) approved this study.
| Setting and data sources
Both WCM and NCH are urban pediatric tertiary care centers. WCM provides primary and specialty care for adults and children, NCH principally for children. Both use the same EHR vendor for ambulatory care (Epic Systems Corp, Verona, WI, USA). We obtained EHR data from each center including demographics, visit history, diagnosis and procedure codes, and outpatient prescription orders from 2013 to 2014 for all children with an epilepsy diagnosis (International Classification of Diseases, Ninth Edition 345.x). We did not include convulsion codes (ie, ICD-9 780.39) as recommended in a recent consensus document 15 because, in the authors' experience, convulsion codes have poor specificity in pediatrics.
| Outcome variable
Our outcome variable "ED visits" was designed to capture the concept of "the child goes to the hospital for urgent medical care." Thus, we included visits that led to hospital admission as well as visits followed by discharge home. We included all ED visits rather than only visits related to seizures and epilepsy for 2 reasons. First, we reasoned that frequent ED use, irrespective of cause, was a compelling marker of social or medical vulnerability. Second, administrative data may not reliably capture the concept of "the child visited the ED due to epilepsy or seizures," because seemingly unrelated diagnostic codes (ie, 536.42 complications of gastrostomy) might be epilepsy related (ie, the gastrostomy was clogged by crushed antiepileptic drug [AED] tablets).
In bivariate statistics, we analyzed 2014 ED visits both as a continuous variable and as a categorical variable. In multivariate statistics and machine learning algorithms, we collapsed 2014 ED visits to a binary outcome. We selected a cutoff to include at least 10% of the individuals in each cohort. At WCM, the cutoff was 1 or more ED visits; at NCH, 2 or more ED visits.
We did not operationalize the concept of "lost to follow-up." Children who did not return to the ED due to clinical improvement were not distinguished from those who moved, died, or sought care elsewhere.
| Predictor variables
We created the following variables in both datasets, with minor differences between centers due to data availability and quality.
| Demographics
We included age and gender. We included ZIP Code-level characteristics extracted from 2000 U.S. Census data (census.gov) as rough proxies of education (percentage of population with 4 years of college education), race and ethnicity (percentage black, percentage Hispanic), and socioeconomic status (SES; percentage of households in poverty). We also calculated the distance between the centroid of the individual's home ZIP Code and the ZIP Code of the hospital. 16 
| Insurance
NCH participates in an accountable care organization (ACO) called Partners for Kids. The ACO is funded by Ohio Medicaid, and is therefore public insurance. However, unlike in Medicaid managed care programs, ACO physicians share financial risk. Furthermore, the ACO provides care management service to many children with chronic disease. Therefore, we categorized insurance as commercial, public ACO, public not ACO, and unknown.
WCM does not have a pediatric ACO. We categorized insurance as commercial, public, or unknown. Public insurance at WCM includes managed Medicaid programs.
At both centers, insurance was "unknown" if no value was in the EHR. This may happen for individuals who are self-pay patients, international patients, uninsured patients, patients transitioning from one insurance to another, or patients who submit bills directly to their insurer.
| Utilization
We included several variables to describe baseline utilization. At both centers, we included the number of ED visits, outpatient visits, inpatient admissions, brain magnetic resonance imaging (MRI) scans, head computed tomography (CT) scans, and electroencephalograms (EEGs). We also included a measure of laboratory services: at NCH, the number of complete blood count (CBC) results; at WCM, AED levels.
| Comorbidities
We assessed 49 comorbidities, using ICD-9 codes from published lists of epilepsy comorbidities for adults 17 supplemented by additional pediatric comorbidities. We categorized patients with the Simon Pediatric Medical
Complexity algorithm ("less conservative" version), which classifies patients into 3 categories (nonchronic, chronic noncomplex, and chronic complex). 18 Finally, a child was "technology dependent" if there was evidence of a gastrostomy tube, tracheostomy, wheelchair, or ventriculoperitoneal shunt (Table 1) .
| Disease severity
We counted the number of AEDs prescribed in 2013 as a marker of disease severity.
| Univariate statistics and comparisons
We provide univariate descriptions of each cohort and a comparison of the 2 cohorts. We used median statistics (median and interquartile interval for descriptions, Wilcox test for comparisons). 20 to estimate the predictability of future ED use. These algorithms gracefully account for nonlinearities, interactions, and unusual distributions common in health care data. 14, 20 However, they can be difficult to interpret, which may be unsatisfactory for clinicians seeking to understand determinants of risk. Thus, we used these algorithms to benchmark our regression models, to understand how much (if any) additional predictive power might be wrought with added computational sophistication.
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| Model evaluation and selection
For both NCH and WCM, we performed twofold crossvalidation repeated 100 times to estimate the median and interquartile interval of the area under the receiver operating curve (AUC). We judged performance as follows: 0.5-0.59, poor predictability; 0.6-0.69, fair; 0.7-0.79, good; 0.8-0.89, very good; and 0.9-1.0, excellent. We selected the logistic regression with the highest AUC. We also provide 2 additional assessments of predictive performance. We calculated calibration as the mean absolute difference between the predicted probability and the observed proportion of frequent ED use across 5 bins of predicted probability (ie, 0%-20%, 20%-40%, etc). We qualified calibration as follows: 0%-4%, excellent; 5%-9%, very good; 10%-14%, good; 15%-20%, fair; and >20% poor. Also, we measured the average number of ED visits among the 5% highest predicted probability identified by each model in the test set during each of the 100 trials of twofold validation.
| Practical evaluation of model 2.6.1 | Score development
To create an interpretable tool for use by clinicians and administrators, we converted the final logistic regression model into a linear scoring system with integer coefficients. We fit the model to the entire dataset, divided the regression coefficients by the smallest coefficient, and rounded to the nearest integer.
| Score characteristics
We provide 3 plots to illustrate properties of the scoring system. First, to show the risk of individuals by score, we plotted score (x-axis) against the observed likelihood that the individual would be a frequent ED user in the subsequent year (y-axis). We highlighted the score that captured the smallest group that included the 5% highest risk patients to visit the ED. Second, to demonstrate the tradeoff between sensitivity and specificity, we plotted a receiver operating curve (ROC). Third, to communicate the expected utilization by different sized cohorts, we plotted the average expected ED use of enrolled individuals against the size of the enrolled cohort.
| Business case analysis
We conducted a business case analysis to estimate the financial effects of an intervention targeted at high-risk patients. We calculated the maximum per-patient-per-year cost of a program that would reduce ED visits by 10% and financially break even, for the cohort with the 5% highest risk. We assumed conservatively that for every 6 ED visits prevented by the intervention, 1 inpatient admission would also be prevented. This was based on our empirical observation that about 1 in 3 ED visits leads to an admission, and an assumption that half of those admissions might be preventable.
We used published estimates of the amount paid in 2013 by a health plan for an average ED visit ($640) and unplanned inpatient admission ($18 066) for a child with epilepsy. 8 We computed 95% confidence intervals (CIs) by applying the score to 1000 bootstrap samples of each dataset.
| Statistical software
We used the R software environment (version 3.0.2), 21 supplemented by additional packages, including "data.table," "car," "ROCR," "randomForest," "ada," "rpart," "e1071," "leaps," "ggplot2," "ggmap," and "glmnet." 3 | RESULTS
| NCH
A total of 2730 children with epilepsy visited NCH in 2013. The median age was 10 years and ranged from 0 to 17. Half (53%) were male. Families lived a median of 24 (interquartile interval = 8-51) miles from NCH. Half had commercial insurance (47%), half public insurance (31% ACO, 19% not ACO), and a small number (2%) had unknown insurance. In 2013, a third (31%) visited the ED at least once, and a quarter (23%) were admitted to the hospital at least once. Patients made a median of 3 (interquartile range [IQR] = 2-6) ambulatory visits to physicians, including a median of 2 (IQR = 1-2) visits to a child neurology provider. One in 5 had a brain MRI (21%), 2 in 5 had an EEG (43%; routine, video, or ambulatory), and 3 in 10 (30%) had at least 1 CBC drawn. Sixty-four percent had at least 1 comorbidity, 58% were medically complex, and 14% were technology dependent. Nearly all (95%) were on an AED. A plurality (44%) were on a single AED; a fifth (22%) were on 3 or more.
| WCM
A total of 786 children with epilepsy visited WCM in 2013. The median age was 10 years, and ranged from 0 to 20. Half (56%) were male. Families lived a median of 7 (IQR = 3-15) miles from WCM. More had private insurance (59%) than public insurance (35%); a small proportion had unknown insurance (6%). In 2013, a third (35%) visited the ED least once, and a third (35%) were admitted at least once. Nearly a quarter had a brain MRI (23%), nearly half (46%) had an EEG (routine or ambulatory), and 2 in 5 (40%) had at least 1 AED level drawn. Forty percent had at least 1 comorbidity; 30% were medically complex; 5% were technology dependent. Three in 10 (30%) were on no AEDs, a third (34%) on a single agent, and 15% on 3 or more.
| Comparison of cohorts
There were significant differences between the cohorts. Although the median age was similar, the WCM cohort included individuals up to 20 years old, whereas the NCH cohort only included children younger than 18 years. WCM patients tended to live closer to the medical center than NCH patients (WCM median = 7, IQR = 3-15 miles vs NCH median = 24, IQR = 8-51 miles). WCM patients lived in areas with a greater proportion of the population identified as black (median = 5%, IQR = 1%-24% vs median = 3%, IQR = 1%-10%) or Hispanic (median = 12%, IQR = 6%-30% vs median = 1%, IQR = 1%-2%) and who lived in households in poverty (median = 13%, IQR = 6%-22% vs median = 10%, IQR = 5%-14%). However, WCM patients also lived in ZIP Codes with a higher proportion who had completed 4 years of college education (median = 25%, IQR = 14%-49% vs median = 15%, IQR = 11%-27%). The WCM patients were more likely to have commercial insurance (59% vs 47%). In 2013, the WCM patients were more likely to visit the ED at least once (35% vs 31%) and more likely to have at least 1 inpatient admission (35% vs 23%). However, the WCM patients made fewer outpatient visits within the WCM network, compared to NCH patients within the NCH network (median = 2, IQR = 1-5 vs median = 4, IQR = 2-9). The WCM patients had fewer comorbidities (median = 0, IQR = 0-1 vs median = 1, IQR = 0-3) and were less likely to be prescribed 3 or more AEDs (15% vs 22%). All cited comparisons were statistically significant.
| Bivariate associations
In both datasets, ED use was associated with younger age, more comorbidity burden, more AEDs, more use of multiple health services, and public insurance. There were some subtleties and exceptions, as follows. At WCM, frequent ED users were more likely to have public insurance; at NCH, frequent ED users were more likely to have non-ACO public insurance. Frequent EEG testing was not associated with frequent ED use at either center. Brain MRIs were associated with frequent ED use at NCH but not WCM (Tables 2 and 3 ). In addition, there were some ZIP Code-level factors associated with frequent ED use, although not consistently at both centers. Frequent ED users at NCH lived closer to the main hospital; this was not observed at WCM. Frequent ED users at WCM were more likely to live in a ZIP Code with a higher percentage of households in poverty; this was not observed at NCH (Tables 2 and 3 ).
| Multivariate models
Random Forest performed best among the machine learning algorithms at both sites, with an AUC indicating very good predictability at NCH, good predictability at WCM, and very good calibration in both datasets ( Table 4 ). The bestperforming logistic regression model at both centers was a 3-variable model that included number of ED visits in 2013, insurance status, and number of different AEDs (ie, a marker of disease severity).
Using the statistical metric AUC, this model modestly underperformed the best machine learning algorithm at NCH (3- 
ED visits leading to admission (IQR) However, when evaluating the expected number of ED visits, the 3-variable model performed equivalently to or better than both machine learning and the 1-variable model. At NCH, individuals in the 5% highest risk cohort identified by the 3-variable model would each be expected to make, on average, 2.9 (IQR = 2.7-3.1) ED visits per year. Performance was not significantly different using 2 of the machine learning algorithms (Random Forest, Lasso), nor 3 simpler regression models. In contrast, at WCM, the 5% highest risk cohort would each be expected to make 2.5 (IQR = 2.2-2.9) ED visits per year. Although one of the simpler regression models performed as well (a 2-concept model with prior ED use and number of AEDs), the other models (4 machine learning and 3 remaining logistic regression) performed inferiorly.
When the 3-variable model was fit to the entire dataset, the coefficients indicated the following. At NCH, the baseline probability of 2 or more ED visits in 2014 was 2.3% (95% CI = 1.7-3.2). Children were more likely to have 2 or more ED visits in 2014 if they had public insurance through the ACO (adjusted odds ratio [OR] = 1.5, 95% CI = 1.1-2.2), public insurance not through the ACO (OR = 2.9, 95% CI = 2-4.1), a higher number of different AEDs prescribed (OR = 1.23, 95% CI = 1.1-1.4 per AED), or a high number of ED visits in 2013 (OR = 1.9, 95% CI = 1.7-2.1 per ED visit; Table 5) .
Similarly, at WCM, the baseline probability of 1 or more ED visits in 2014 was 3.2% (95% CI = 1.9%-5.2%). Children were more likely to have an ED visit if they had public insurance (OR = 4, 95% CI = 2.4-6.8), a higher number of different AEDs prescribed (OR = 1.24, 95% CI = 1.05-1.5 per AED), or a high number of ED visits in 2013 (OR = 1.9, 95% CI = 1.5-2.5 per ED visit; Table 5 ).
| Scoring systems
After dividing by the smallest regression coefficient and rounding to whole numbers, a 3-variable scoring system categorized individuals by risk of ED use as follows. At each center, assign 1 point for each different AED prescribed in the past year, and 3 points for each ED visit in the past year. A child at NCH receives 2 additional points if insured by the public ACO, and 5 points if they have public insurance not through the ACO; a child at WCM gets 6 points for public insurance (Table 5 ). Visual analysis demonstrates that higher scores indicated higher risk at each center ( Figure 1 ). The ROCs indicated high specificity and low sensitivity when recruiting small cohorts (Figure 1) . Graphing the enrollment size against the expected number of ED visits per patient per year highlights the increased number of ED visits per patient in small cohorts (Figure 1 ). If these models were used to recruit individuals into an intervention that reduced ED visits by 10%, the per-patient-per-year breakeven point using the 3-variable model would be $958 ($568-$1390) at WCM, and $1086 ($886-$1320) at NCH.
| DISCUSSION
| Summary
A 3-variable prediction system incorporating history of ED use, insurance status, and a marker of disease severity (number of different AEDs) accurately predicted frequent ED use among children with epilepsy at 2 academic medical centers, despite significant differences between the 2 populations. The practical predictive performance was (WCM; B) . The gray area indicates the group with the 5% highest risk, at a threshold score of 15 at both centers. C, D, The receiver operating curves demonstrate that recruiting smaller cohorts will identify high-risk patients with high specificity but low sensitivity at NCH (C) and WCM (D). E, F, The mean number of expected ED visits in a cohort of the 5% highest risk patients (dotted lines) is 3 for NCH (E) and 2.5 for WCM (F) similar or superior to machine learning, suggesting that more complex models are unlikely to provide additional benefit. The business case analysis indicated that ED use was sufficiently predictable to justify hiring staff to work with frequent ED users. Specifically, the analysis supports spending approximately $1000 per patient per year on an intervention targeted at the 5% highest risk population, assuming (1) the intervention reduces ED visits by 10%, (2) 1 in 6 ED visits leads to a preventable inpatient admission, and (3) health care costs are similar to published rates. 8 use of specialty care, 27 and patient engagement (ie, missed appointments). 24 For people with epilepsy, several factors are associated with frequent ED use, including care delivery factors (visiting a "low SES clinic"), 11 individual factors (lower knowledge, stigma, and suboptimal self-management), and epilepsy factors (frequent seizures). 9,10 Our previous work found that prior ED visits alone could predict future ED visits. 14 Our current work demonstrates that adding markers of insurance status and disease severity modestly improved predictive performance.
| Comparison to prior work
| Insurance and site of care
Our findings implicitly demonstrate how 2 health system factors can impact care for children with epilepsy: insurance 28 and location of care.
11
At WCM (as with all academic centers in New York City), children with public insurance often receive outpatient care in resident-run clinics (ie, "low SES clinic"), whereas children with commercial insurance visit faculty practices in a different location (ie, "high SES clinic"). Thus, the higher risk assigned to children with public insurance may reflect differences in care delivered at these 2 sites.
In contrast, at NCH, all children with epilepsy receive care at the same location, with the same staff and providers. However, ACO enrollees often receive enhanced outpatient services such as care coordination. The lower risk assigned to ACO enrollees raises the possibility that these services protect against frequent ED use.
| Disease severity
It is not surprising that children taking more AEDs were at higher risk to visit the ED. Children taking several AEDs often have uncontrolled seizures, 29 and therefore may have appropriate reasons to visit the ED, such as breakthrough seizures, increased seizure frequency, or status epilepticus.
| Generalizability
In the 3-variable model, the points assigned to the insurance variable were different at the 2 centers, creating some ambiguity about how to generalize the model. There are 3 choices: (1) select either the WCM or NCH point system based on the insurance market at the local center (ie, is there a public insurance ACO?), (2) use a 1-variable model (ie, number of ED visits in the past year), or (3) gather center-specific data and create center-specific values for the variables. Further research is indicated to evaluate the relative merits of these choices. Of importance, implementing the 3-variable model may require additional informatics expertise compared to the 1-variable model, in that it requires a reliable mechanism to count AEDs.
| Implications for intervention design
Although the final model contained only 3 variables, many other variables were associated with frequent ED use, although they lacked additional predictive value. Frequent ED users were young, medically complex, and frequent users of other health services. Thus, interventions might apply broadly applicable strategies for chronic illness care, such as multidisciplinary clinics, care coordinators, support services for parents, social work services, or home visits. Growing evidence suggests tailored care delivery for high-risk patients, such as care management, 5 checklists, 6 education in the ED, 7 and epilepsy-focused urgent care clinics, 8 have the potential to improve care for people with epilepsy. Of importance, our analysis focused on all ED use rather than only seizure-related ED use. Thus, for some children, interventions solely focused on improving epilepsy care may be insufficient to reduce overall ED use. Further work is needed to describe the patients who may benefit from these interventions, 30 establish generalizability, and understand models of payment that best support such interventions.
| Limitations
First, there were important unmeasured variables that may add predictive power, such as health perceptions, 31 impact on the family, 32 education, stigma, and self-efficacy. 9,10 Second, people with epilepsy often visit multiple centers, 33 and an EHR may not fully capture their care. Third, the most predictive variable is prior ED use, which means that high-risk patients are already in need of support-ie, our predictions are reactive rather than proactive. Fourth, ICD-9 codes only have moderate accuracy for identifying children with epilepsy. 34 In particular, we did not include the neonatal seizure code (779.0), and may have undercounted neonates. Fifth, high-risk patients may not respond to interventions designed to reduce ED use, particularly because some ED visits are necessary (ie, not preventable) for children with epilepsy. Further research is necessary to understand (1) if an intervention can successfully reduce ED use among high-risk patients, and (2) which children respond to interventions designed to prevent unnecessary hospital use. 30 
| CONCLUSIONS
Prior ED use, insurance status, and disease severity, taken together, predict future frequent ED use for children with epilepsy. Further work is indicated to develop and evaluate the effect of interventions targeted toward high-risk children.
